Compare Pfizer with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DR. REDDYS LAB - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DR. REDDYS LAB PFIZER/
DR. REDDYS LAB
 
P/E (TTM) x 36.0 16.9 213.3% View Chart
P/BV x 6.1 3.2 188.0% View Chart
Dividend Yield % 0.6 0.7 76.9%  

Financials

 PFIZER   DR. REDDYS LAB
EQUITY SHARE DATA
    PFIZER
Mar-19
DR. REDDYS LAB
Mar-19
PFIZER/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3,8402,875 133.6%   
Low Rs2,0801,888 110.2%   
Sales per share (Unadj.) Rs455.0930.2 48.9%  
Earnings per share (Unadj.) Rs93.8117.4 79.9%  
Cash flow per share (Unadj.) Rs109.4185.8 58.9%  
Dividends per share (Unadj.) Rs22.5020.00 112.5%  
Dividend yield (eoy) %0.80.8 90.5%  
Book value per share (Unadj.) Rs658.2844.4 77.9%  
Shares outstanding (eoy) m45.75166.07 27.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.52.6 254.1%   
Avg P/E ratio x31.620.3 155.6%  
P/CF ratio (eoy) x27.112.8 211.1%  
Price / Book Value ratio x4.52.8 159.5%  
Dividend payout %24.017.0 140.9%   
Avg Mkt Cap Rs m135,420395,496 34.2%   
No. of employees `0002.622.0 12.0%   
Total wages/salary Rs m3,23833,562 9.6%   
Avg. sales/employee Rs Th7,911.47,032.8 112.5%   
Avg. wages/employee Rs Th1,230.91,527.9 80.6%   
Avg. net profit/employee Rs Th1,630.7887.7 183.7%   
INCOME DATA
Net Sales Rs m20,815154,482 13.5%  
Other income Rs m1,6743,375 49.6%   
Total revenues Rs m22,489157,857 14.2%   
Gross profit Rs m5,71231,782 18.0%  
Depreciation Rs m71411,348 6.3%   
Interest Rs m73889 8.2%   
Profit before tax Rs m6,59922,920 28.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3093,858 59.8%   
Profit after tax Rs m4,29119,500 22.0%  
Gross profit margin %27.420.6 133.4%  
Effective tax rate %35.016.8 207.8%   
Net profit margin %20.612.6 163.3%  
BALANCE SHEET DATA
Current assets Rs m27,167111,101 24.5%   
Current liabilities Rs m8,91758,973 15.1%   
Net working cap to sales %87.733.7 259.8%  
Current ratio x3.01.9 161.7%  
Inventory Days Days6879 85.5%  
Debtors Days Days3094 32.0%  
Net fixed assets Rs m8,862101,245 8.8%   
Share capital Rs m458830 55.1%   
"Free" reserves Rs m29,656139,406 21.3%   
Net worth Rs m30,113140,236 21.5%   
Long term debt Rs m2522,000 0.1%   
Total assets Rs m39,400224,656 17.5%  
Interest coverage x91.526.8 341.7%   
Debt to equity ratio x00.2 0.5%  
Sales to assets ratio x0.50.7 76.8%   
Return on assets %11.19.1 122.0%  
Return on equity %14.213.9 102.5%  
Return on capital %22.114.9 148.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42888,673 0.5%   
Fx outflow Rs m78619,104 4.1%   
Net fx Rs m-35869,569 -0.5%   
CASH FLOW
From Operations Rs m97828,704 3.4%  
From Investments Rs m351-7,727 -4.5%  
From Financial Activity Rs m-1,099-21,326 5.2%  
Net Cashflow Rs m231-314 -73.5%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 4.9 35.3 13.9%  
ADR/GDR % 0.0 18.5 -  
Free float % 23.7 15.3 154.9%  
Shareholders   85,207 75,885 112.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  SANOFI INDIA  

Compare PFIZER With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Higher; IT and Banking Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended higher. Benchmark Indices were highly volatile swinging between positive and negative territory.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 14, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS